نتایج جستجو برای: eluting stents

تعداد نتایج: 19304  

Journal: :Revista espanola de cardiologia 2009
Ramón López-Palop Pilar Carrillo Araceli Frutos Alberto Cordero Daniel Núñez Marlon Toro Vicente Bertomeu-Martínez

INTRODUCTION AND OBJECTIVES The effectiveness of coronary drug-eluting stents has not been fully studied in very elderly patients who have clinical features that predispose them to side effects and long-term adverse events. METHODS The safety and efficacy of drug-eluting stents were studied in a historical cohort of consecutive octogenarian patients who underwent percutaneous coronary interve...

2011
Davran Çiçek Hasan Pekdemir Cevahir Haberal Nihat Kalay Süleyman Binici Hakan Altay Haldun Müderrisoğlu

BACKGROUND Our purpose was to investigate the clinical outcomes of Zotarolimus- and Paclitaxel-eluting stents in Turkish patients with coronary artery disease (CAD). In general, the outcome of drug-eluting stent (DES) placement has a proven efficacy in randomized trials. However, the difference in efficacy between the Zotarolimus and Paclitaxel-eluting stents in unselected Turkish patients is c...

Journal: :European heart journal 2006
Alain Joel Nordmann Matthias Briel Heiner Claudins Bucher

AIMS To evaluate the effect of drug-eluting vs. bare metal stents for the treatment of coronary artery disease on overall, cardiac, and non-cardiac mortalities. METHODS AND RESULTS We conducted a systematic literature search to identify all randomized controlled trials comparing sirolimus or paclitaxel-eluting stents with bare metal stents and reporting mortality data after at least 1 year of...

Journal: :Circulation 2004
Dirk H Walter Manfred Cejna Larry Diaz-Sandoval Sean Willis Laura Kirkwood Peter W Stratford Anne B Tietz Rudolf Kirchmair Marcy Silver Cindy Curry Andrea Wecker Young-Sup Yoon Regina Heidenreich Allison Hanley Marianne Kearney Fermin O Tio Patrik Kuenzler Jeffrey M Isner Douglas W Losordo

BACKGROUND Drug-eluting stents represent a useful strategy for the prevention of restenosis using various antiproliferative drugs. These strategies share the liability of impairing endothelial recovery, thereby altering the natural biology of the vessel wall and increasing the associated risk of stent thrombosis. Accordingly, we tested the hypothesis that local delivery via gene-eluting stent o...

Journal: :Circulation. Cardiovascular interventions 2015
Tobias Koppara Qi Cheng Kazuyuki Yahagi Hiroyoshi Mori Oscar David Sanchez Julia Feygin Eric Wittchow Frank D Kolodgie Renu Virmani Michael Joner

BACKGROUND Acute thrombogenicity and re-endothelialization represent clinically relevant end points pertaining to the safety of coronary stents, which have not been compared among biodegradable polymer-based drug-eluting metallic stents and fully bioabsorbable scaffolds to date. METHODS AND RESULTS We investigated comparative outcomes with respect to acute thrombogenicity and re-endothelializ...

2016
Alev Arat Ozkan Umit Yasar Sinan Aziz T Gurmen

Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%-3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies. Sirolimus-eluting stents with their closed cell design were reported to be more prone to fracture compared to paclitaxel-eluting stents. Other risk factors for stent fracture are multiple ste...

Journal: :The European journal of cardiovascular medicine 2010
Kamal Chitkara Kushal Pujara

Over the past decade, the advent of drug-eluting stents (DES) has revolutionised the field of interventional cardiology by having a major impact on patient care through their efficacy in reducing the need for repeat revascularisation. A number of stents capable of delivering an anti-proliferative agent designed to prevent neointimal hyperplasia, the principal mechanism of restenosis after stent...

Journal: :Journal of the American College of Cardiology 2008
Eloi Marijon Xavier Jouven

Cardiol 2007;50:1305–9. 2. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193–202. 3. Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005;46:231–6. 4. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to ...

2016
Shabnam Rashid

The risk of stent thrombosis and restenosis with the second generation drug eluting stents remains. The bioresorbable vascular scaffold is a third generation stent and overcomes the problems associated with drug eluting metallic stents. The bioresorbable vascular scaffold completely absorbs within the coronary vessel over 3-5 years. Multiple trials in patients with non complex coronary disease ...

Journal: :Circulation journal : official journal of the Japanese Circulation Society 2008
Shinji Kanemitsu Keizo Tanaka Jin Tanaka Hitoshi Suzuki Toshihiko Kinoshita

Two cases of drug-eluting stent restenosis after percutaneous coronary intervention in the left main coronary artery and its bifurcation are presented. An off-pump coronary artery bypass grafting following in-stent restenosis was performed. Drug-eluting stents have shown a reduced frequency of in-stent restenosis and a good safety profile compared with bare metal stents. However, intervention w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید